Total planned funding: $393,759,298

Allocations

$393,759,298

Private Contractor	$164,747,989
Unknown	$89,503,645
University	$50,860,666
NGO	$42,592,857
Own Agency	$28,994,880
Implementing Agency	$14,889,329
Multi-lateral Agency	$1,757,500
Host Country Government Agency	$412,432
Other USG Agency	$0

HTXD: Treatment: ARV Drugs	$94,980,937
HTXS: Treatment: Adult Treatment	$88,334,826
HKID: Care: Orphans and Vulnerable Children	$35,427,626
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision	$33,842,023
HVCT: Testing: HIV Testing and Counseling	$30,272,378
OHSS: Health Systems Strengthening	$18,391,027
HVMS: Management and Operations	$16,724,739
HVTB: Care: TB/HIV	$14,177,400
PDTX: Treatment: Pediatric Treatment	$11,491,584
HVOP: Sexual Prevention: Other Sexual Prevention	$11,290,796
HBHC: Care: Adult Care and Support	$10,953,945
PDCS: Care: Pediatric Care and Support	$7,186,704
HLAB: Laboratory Infrastructure	$6,483,011
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission	$6,464,087
HVSI: Strategic Information	$4,971,231
HVAB: Sexual Prevention: Abstinence/Be Faithful	$2,359,691
IDUP: Prevention: Injecting and Non-Injecting Drug Use	$269,128
HMBL: Biomedical Prevention: Blood Safety	$103,733
HMIN: Biomedical Prevention: Injection Safety	$34,432